Raggio-Italgene signs Cystic Fibrosis (CF) screening agreement
This article was originally published in Clinica
Executive Summary
One of Italy's leading cystic fibrosis reference centres will use Raggio-Italgene's C-Trak Cystic Fibrosis Plus DNA-probe kit for the screening of newborns and carriers. The agreement also involves the development of a customised kit for the most frequently encountered mutations in the Italian population.